Publications by authors named "Ataru Inagaki"

Claim this Profile
A
A randomized, double-blinded, placebo-controlled study to evaluate the efficacy and safety of venlafaxine extended release in Japanese patients with generalized anxiety disorder.
Tempei Otsubo, Koichiro Watanabe, Takeshi Inoue, Ataru Inagaki, Toshiaki Kikuchi

Psychiatry Clin Neurosci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Increased Antidepressant Prescriptions for Children and Adolescents with Major Depressive Disorder in Japan Based on a Claims Database.
Keisuke Nomoto, Ataru Inagaki, Keita Yamauchi

Neuropsychiatr Dis Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of long-acting injections for the treatment of Schizophrenia in Japan.
Mami Kasahara-Kiritani, Chu-Chu Sheng, Nan Li, Akihide Wakamatsu, Sonja Sorensen, Ataru Inagaki

Asian J Psychiatr· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between readmission and patient-reported measures in acute psychiatric inpatients: a multicenter prospective longitudinal study.
Sosei Yamaguchi, Yasutaka Ojio, Junko Koike, Asami Matsunaga, Makoto Ogawa, Ataru Inagaki

Soc Psychiatry Psychiatr Epidemiol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Authors' Reply: Japan's Telepsychiatry Dissemination: Current Status and Challenges.
Yuka Sugawara, Yosuke Hirakawa, Masao Iwagami, Haruo Kuroki, Shuhei Mitani, Ataru Inagaki

J Med Internet Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.
Yuka Sugawara, Yosuke Hirakawa, Masao Iwagami, Haruo Kuroki, Shuhei Mitani, Ataru Inagaki

J Med Internet Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Issues in the Adoption of Online Medical Care: Cross-Sectional Questionnaire Survey.
Yuka Sugawara, Yosuke Hirakawa, Masao Iwagami, Haruo Kuroki, Shuhei Mitani, Ataru Inagaki

J Med Internet Res· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Budget impact analysis of long acting injection for schizophrenia in Japan.
Mami Kasahara-Kiritani, Amish Chaturvedi, Ataru Inagaki, Akihide Wakamatsu, Wonjoo Jung

J Med Econ· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan.
Nakao Iwata, Ataru Inagaki, Hiromi Sano, Kazunari Niidome, Yoshitsugu Kojima

Adv Ther· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Associations between readmission and patient-reported measures in acute psychiatric inpatients: a study protocol for a multicenter prospective longitudinal study (the ePOP-J study).
Sosei Yamaguchi, Yasutaka Ojio, Junko Koike, Asami Matsunaga, Makoto Ogawa, Ataru Inagaki

Int J Ment Health Syst· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Safety of Long-acting Injectable Antipsychotics Is Long-acting Injection a High-risk Treatment Option?].
Ataru Inagaki

Seishin Shinkeigaku Zasshi· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Dr. Okumura.
Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, Toshiya Inada, Takashi Yoshio

Int J Neuropsychopharmacol· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Individually Safe and Realistic Correction of Antipsychotic Polypharmacy and High-dose Regimens in Japanese Patients with Chronic Schizophrenia: The SCAP method].
Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, Toshiya Inada, Takashi Yoshio

Seishin Shinkeigaku Zasshi· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Psychotropic dose equivalence in Japan.
Toshiya Inada, Ataru Inagaki

Psychiatry Clin Neurosci· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.
Yoshio Yamanouchi, Tsuruhei Sukegawa, Ataru Inagaki, Toshiya Inada, Takashi Yoshio

Int J Neuropsychopharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Influence of patient characteristics on care time in patients hospitalized with schizophrenia.
Yukiko Sugibayashi, Kimio Yoshimura, Keita Yamauchi, Ataru Inagaki, Naoki Ikegami

Neuropsychiatr Dis Treat· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Metabolic and lithium monitoring in Japanese psychiatric outpatient clinics].
Ataru Inagaki, Tadashi Takeshima

Seishin Shinkeigaku Zasshi· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: safety correction of high dose antipsychotic polypharmacy in Japan.
Tsuruhei Sukegawa, Ataru Inagaki, Yoshio Yamanouchi, Toshiya Inada, Takashi Yoshio

BMC Psychiatry· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost of anxiety disorders in Japan in 2008: a prevalence-based approach.
Mitsuhiro Sado, Sayuri Takechi, Ataru Inagaki, Daisuke Fujisawa, Akihiro Koreki

BMC Psychiatry· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Temporal relationship between multiple drugs and multiple events in patient reports on adverse drug reactions: findings in a pilot study in Japan.
Kiyoshi Kubota, Mitsuhiro Okazaki, Akira Dobashi, Michiko Yamamoto, Masayuki Hashiguchi, Ataru Inagaki

Pharmacoepidemiol Drug Saf· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia.
Jinichi Hirano, Koichiro Watanabe, Takefumi Suzuki, Hiroyuki Uchida, Ryosuke Den, Ataru Inagaki

Neuropsychiatr Dis Treat· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost of schizophrenia in Japan.
Mitsuhiro Sado, Ataru Inagaki, Akihiro Koreki, Martin Knapp, Lee Andrew Kissane

Neuropsychiatr Dis Treat· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survey on the actual condition of psychiatrists and psychiatric services in Japan. (Part 1): Basic data on number and distribution of psychiatrists].
Masafumi Mizuno, Ataru Inagaki, Shuichiro Fujiwara, Fusako Enokido, Naohisa Tsujino

Seishin Shinkeigaku Zasshi· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Survey on the actual condition of psychiatrists and psychiatric services in Japan. (Part 2): Change in geographical working area and setting of each psychiatrist].
Ataru Inagaki, Masafumi Mizuno, Shuichiro Fujiwara, Fusako Enokido, Naohisa Tsujino

Seishin Shinkeigaku Zasshi· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Dose adjustment of multiple drugs administration for schizophrenia and QOL].
Ataru Inagaki

Seishin Shinkeigaku Zasshi· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis